— Know what they know.
Not Investment Advice
Also trades as: MRMD.CN (CNQ) · $vol 0M

MRMD OTC

MariMed Inc.
1W: -10.4% 1M: -11.0% 3M: +1.9% YTD: -23.3% 1Y: -57.1% 3Y: -84.2% 5Y: -92.8%
$0.07
-0.00 (-0.86%)
 
Weekly Expected Move ±7.0%
$0 $0 $0 $0 $0
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Sell · Power 43 · $27.5M mcap · 332M float · 0.155% daily turnover · Short 18% of daily vol
Smart Money Score
No convergence signal
Key Statistics
Market Cap$27.5M
52W Range0.061-0.178
Volume235,405
Avg Volume513,004
Beta1.36
Dividend—
Analyst Ratings
1 Buy 0 Hold 0 Sell
Consensus Buy
Company Info
CEOJon R. Levine
Employees866
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date2012-08-03
10 Oceana Way
Norwood, MA 02062
US
617 795 5140
About MariMed Inc.

MariMed Inc. operates in the cannabis industry, specializing in the cultivation, production, and sale of both medicinal and adult-use cannabis items throughout the United States and internationally. The company's diverse product portfolio includes cannabis flowers and concentrates marketed under the Nature's Heritage brand. It also offers infused goods such as chewable tablets and powdered drink mixes under the Kalm Fusion label, natural fruit chews known as Betty's Eddies, and a line of baked treats like brownies and cookies available through Bubby's Baked. Furthermore, MariMed develops cannabidiol (CBD) products under the Florance brand. Beyond its own offerings, the company licenses its various brands and product formulations to others and leases facilities designed for cannabis operations. MariMed Inc., founded in 2011, is based in Norwood, Massachusetts.

Recent Insider Trades

NameTypeSharesPriceDate
Shaw Timothy M-Exempt 9,981 — 2026-10-02
Shaw Timothy F-InKind 3,459 $0.07 2026-10-02
Shaw Timothy M-Exempt 9,981 — 2026-10-02
Levine Jon R M-Exempt 11,517 — 2026-10-02
Levine Jon R F-InKind 3,991 $0.07 2026-10-02

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms